Display Settings:

Format

Send to:

Choose Destination
    J Org Chem. 2009 Dec 4;74(23):8997-9009.

    From imide to lactam metallo-pyridocarbazoles: distinct scaffolds for the design of selective protein kinase inhibitors.

    Source

    Fachbereich Chemie, Philipps-Universität Marburg, Hans-Meerwein-Strasse, 35032 Marburg, Germany.

    Abstract

    Organometallic pyridocarbazole scaffolds are investigated as protein kinase inhibitors. Whereas our previous designs employed solely a maleimide pharmacophore for achieving the two crucial canonical hydrogen bonds to the hinge region of the ATP binding site, we have now extended our investigations to include the related lactam metallo-pyridocarbazoles. The synthetic access of the two regioisomeric lactam pyridocarbazoles is described, and the distinct biological properties of the two lactam scaffolds are revealed by employing a ruthenium half sandwich complex as a model system, resulting in organometallic lead structures for the inhibition of the protein kinases TrkA and CLK2. These new lactam metallo-pyridocarbazoles expand our existing molecular toolbox and assist toward the generation of metal complex scaffolds as lead structures for the design of selective inhibitors for numerous kinases of the human kinome.

    PMID:
    19886617
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2788055
    Free PMC Article

    Images from this publication.See all images (10) Free text

    FIGURE 1
    FIGURE 3
    FIGURE 5
    SCHEME 2
    SCHEME 4
    FIGURE 2
    FIGURE 4
    SCHEME 1
    SCHEME 3
    SCHEME 5

      Supplemental Content

      Icon for American Chemical Society Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk